Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 86
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
J Endocrinol Invest ; 40(6): 669-678, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28161880

RESUMEN

PURPOSE: To report the long-term effectiveness and safety of the recombinant human growth hormone Omnitrope®, a somatropin biosimilar to Genotropin®, in Italian patients with growth hormone deficiency (GHD) enrolled in the PATRO Adults study. METHODS: The PATRO Adults study is an ongoing observational, longitudinal, non-interventional global post-marketing surveillance study, conducted in several European countries. The primary endpoint is long-term safety; secondary endpoints include the effectiveness of Omnitrope®, which was assessed using serum insulin-like growth factor-1 levels, body composition, bone mineral density and lipid levels. Here we report the data from the Italian patients enrolled in the study. RESULTS: Sixty-seven patients (mean age 50.4 years, 61.2% male) have been enrolled and have received a mean 45.4 ± 24.3 months of Omnitrope®. A total of 55.2% of patients were reported to have experienced adverse events (AEs), including arthralgia, myalgia, abdominal distension and hypoaesthesia, and 4.5% had adverse drug reactions. Fourteen serious AEs have been recorded; none of these are considered related to the study drug. The effectiveness of Omnitrope® was similar to other available somatropin preparations. CONCLUSIONS: This study confirms the effectiveness and safety of Omnitrope® in adult patients with GHD in Italy. However, due to the limited size of the study population, these results need to be further confirmed by the global PATRO Adults study.


Asunto(s)
Estatura/efectos de los fármacos , Densidad Ósea/efectos de los fármacos , Trastornos del Crecimiento/tratamiento farmacológico , Hormona de Crecimiento Humana/uso terapéutico , Adulto , Anciano , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Seguridad
2.
Amino Acids ; 47(3): 637-50, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25595600

RESUMEN

The Disrupted-in-schizophrenia 1 (DISC1) gene is involved in vulnerability to neuropsychiatric disorders. Naples high-excitability (NHE) rat model neuropsychiatric problems characterized by an unbalanced mesocortical dopamine system. Here, we assessed behavioral and neurochemical effects of immunization against multimeric rat DISC1 protein in adult NHE rats, an animal model of attention-deficit hyperactivity disorder and their Random-Bred (NRB) controls. Males of both lines received subcutaneous injections of vehicle (PB), adjuvant only (AD) or recombinant rat DISC1 protein purified from E. coli, suspended in AD (anti-DISC1) at age of 30, 45 and 60 postnatal days (pnd). At 75 pnd, the rats were exposed to a Làt maze and 2 days later to an Olton eight-arm radial maze, and horizontal (HA) and vertical activities (VA) were monitored. Non-selective (NSA) and selective spatial attention (SSA) were monitored in the Làt and in the Olton maze by duration of rearings and working memory, respectively. Post mortem neurochemistry in the prefrontal cortex (PFc), dorsal (DS) and ventral (VS) striatum of L-Glutamate, L-Aspartate and L-Leucine was performed. All immunized rats showed a clear humoral IgM (but not IgG) immune response against the immunogen, indicating that immunological self-tolerance to DISC1 can be overcome by immunization. NHE rats exhibited a higher unspecific IgM response to adjuvant, indicating an immunological abnormality. The sole anti-DISC1 immunization-specific behavioral in the NHE rats was an increased horizontal activity in the Làt maze. Adjuvant treatment increased vertical activity in both lines, but in the NRB controls it increased rearing and decreased horizontal activity. Liquid chromatography/tandem mass spectrometry analysis of soluble or membrane-trapped neurotransmitters aspartate, glutamate and leucine revealed increased soluble aspartate levels in the ventral striatum of NRB controls after anti-DISC1 immunization. Immune activation by adjuvant independent of simultaneous DISC1 immunization led to other specific changes in NHE and control NRB rats. In DISC1-immunized NHE rats, horizontal activity in Lat maze correlated with membrane-trapped glutamate in PFc and in the NRB rats, duration of rearing in Olton maze correlated with membrane-trapped glutamate in PFc and aspartate in dorsal striatum. In addition to non-specific immune activation (by AD), the postnatal anti-DISC1 immune treatment led to behavioral changes related to mechanisms of activity and attention and had influenced amino acids and synaptic markers in striatum and neocortex in the adult NHE as well as control animals.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/metabolismo , Aminoácidos Excitadores/metabolismo , Inmunización , Proteínas del Tejido Nervioso/efectos adversos , Corteza Prefrontal/metabolismo , Animales , Trastorno por Déficit de Atención con Hiperactividad/inducido químicamente , Trastorno por Déficit de Atención con Hiperactividad/inmunología , Trastorno por Déficit de Atención con Hiperactividad/fisiopatología , Conducta Animal/efectos de los fármacos , Química Encefálica/efectos de los fármacos , Aminoácidos Excitadores/inmunología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Proteínas del Tejido Nervioso/inmunología , Proteínas del Tejido Nervioso/farmacología , Corteza Prefrontal/inmunología , Corteza Prefrontal/fisiopatología , Ratas , Ratas Sprague-Dawley
3.
Colorectal Dis ; 17(1): O10-9, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25213152

RESUMEN

AIM: This multicentre study, based on the largest patient population ever published, aims to evaluate the efficacy of Doppler-guided transanal haemorrhoidal dearterialization (THD Doppler) in the treatment of symptomatic haemorrhoids and to identify the factors predicting failure for an effective mid-term outcome. METHOD: Eight hundred and three patients affected by Grade II (137, 17.1%), III (548, 68.2%) and IV (118, 14.7%) symptomatic haemorrhoidal disease underwent THD Doppler, with a rectal mucopexy in patients with haemorrhoidal prolapse. The disease was assessed through a specifically designed symptom questionnaire and scoring system. A uni- and multivariate analyses of the potential predictive factors for failure were performed. RESULTS: The morbidity rate was 18.0%, represented mainly by pain or tenesmus (106 patients, 13.0%). Acute bleeding requiring surgical haemostasis occurred in seven patients (0.9%). No serious or life-threatening complications occurred. After a mean follow-up period of 11.1 ± 9.2 months, the overall success rate was 90.7% (728 patients), with a recurrence of haemorrhoidal prolapse, bleeding, and both symptoms in 51 (6.3%), 19 (2.4%) and 5 (0.6%) patients, respectively. Sixteen out of 47 patients undergoing re-operation had a conventional haemorrhoidectomy. All the symptoms were significantly improved in each domain of the score (P < 0.0001). At multivariate analysis the absence of morbidity and performance of a distal Doppler-guided dearterialization were associated with a better outcome. CONCLUSION: THD Doppler is a safe and effective therapy for haemorrhoidal disease. If this technique is to be employed, an accurate distal Doppler-guided dearterialization and a tailored mucopexy are mandatory to contain and reduce the symptoms.


Asunto(s)
Canal Anal/irrigación sanguínea , Canal Anal/cirugía , Hemorroides/cirugía , Recto/irrigación sanguínea , Recto/cirugía , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Canal Anal/diagnóstico por imagen , Arterias , Femenino , Hemorreoidectomía , Hemorroides/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Morbilidad , Dolor Postoperatorio/epidemiología , Hemorragia Posoperatoria/epidemiología , Prolapso Rectal/cirugía , Recto/diagnóstico por imagen , Recurrencia , Reoperación , Resultado del Tratamiento , Ultrasonografía Doppler , Adulto Joven
4.
Amino Acids ; 46(9): 2105-22, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24862315

RESUMEN

Intranasal application of dopamine (IN-DA) has been shown to increase motor activity and to release DA in the ventral (VS) and dorsal striatum (DS) of rats. The aim of the present study was to assess the effects of IN-DA treatment on parameters of DA and excitatory amino acid (EAA) function in prepuberal rats of the Naples high-excitability (NHE) line, an animal model for attention-deficit hyperactivity disorder (ADHD) and normal random bred (NRB) controls. NHE and NRB rats were daily administered IN-DA (0.075, 0.15, 0.30 mg/kg) or vehicle for 15 days from postnatal days 28-42 and subsequently tested in the Làt maze and in the Eight-arm radial Olton maze. Soluble and membrane-trapped L-glutamate (L-Glu) and L-aspartate (L-Asp) levels as well as NMDAR1 subunit protein levels were determined after sacrifice in IN-DA- and vehicle-treated NHE and NRB rats in prefrontal cortex (PFc), DS and VS. Moreover, DA transporter (DAT) protein and tyrosine hydroxylase (TH) levels were assessed in PFc, DS, VS and mesencephalon (MES) and in ventral tegmental area (VTA) and substantia nigra, respectively. In NHE rats, IN-DA (0.30 mg/kg) decreased horizontal activity and increased nonselective attention relative to vehicle, whereas the lower dose (0.15 mg/kg) increased selective spatial attention. In NHE rats, basal levels of soluble EAAs were reduced in PFc and DS relative to NRB controls, while membrane-trapped EAAs were elevated in VS. Moreover, basal NMDAR1 subunit protein levels were increased in PFc, DS and VS relative to NRB controls. In addition, DAT protein levels were elevated in PFc and VS relative to NRB controls. IN-DA led to a number of changes of EAA, NMDAR1 subunit protein, TH and DAT protein levels in PFc, DS, VS, MES and VTA, in both NHE and NRB rats with significant differences between lines. Our findings indicate that the NHE rat model of ADHD may be characterized by (1) prefrontal and striatal DAT hyperfunction, indicative of DA hyperactivty, and (2) prefrontal and striatal NMDA receptor hyperfunction indicative of net EAA hyperactivty. IN-DA had ameliorative effects on activity level, attention, and working memory, which are likely to be associated with DA action at inhibitory D2 autoreceptors, leading to a reduction in striatal DA hyperactivity and, possibly, DA action on striatal EAA levels, resulting in a decrease of striatal EAA hyperfunction (with persistence of prefrontal EAA hyperfunction). Previous studies on IN-DA treatment in rodents have indicated antidepressant, anxiolytic and anti-parkinsonian effects in relation to enhanced central DAergic activity. Our present results strengthen the prospects of potential therapeutic applications of intranasal  DA by indicating an enhancement of selective attention and working memory in a deficit model.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad , Dopaminérgicos/farmacología , Dopamina/farmacología , Maduración Sexual , Estriado Ventral , Administración Intranasal , Animales , Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Trastorno por Déficit de Atención con Hiperactividad/metabolismo , Trastorno por Déficit de Atención con Hiperactividad/fisiopatología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Humanos , Masculino , Ratas , Ratas Sprague-Dawley , Estriado Ventral/metabolismo , Estriado Ventral/fisiopatología
5.
Nutr Metab Cardiovasc Dis ; 23(11): 1134-40, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23220075

RESUMEN

BACKGROUND AND AIMS: Prader-Willi syndrome (PWS), the most common genetic cause of obesity, is characterized by elevated morbility and mortality in all ages. In this context, non-obese PWS children showed low frequency of metabolic syndrome (MetS), while a comparable prevalence was observed in obese PWS and obese controls. Aim of this study was to estimate the occurrence of MetS and its components in a large group of PWS adults, according to obesity status. METHODS AND RESULTS: A cross-sectional study was performed in 108 PWS aged 18.0-43.2 years (87 obese and 21 non-obese) and in 85 controls with nonsyndromic obesity matched for age, gender, and BMI with obese PWS. Non-obese PWS showed lower waist circumference, insulin, HOMA-index, triglycerides, diastolic blood pressure, and higher HDL-C than both obese PWS and obese controls (p < 0.017). Obese PWS showed higher glucose and systolic blood pressure than both non-obese PWS and obese controls (p < 0.017). MetS was found in 1/21 (4.8%) non-obese PWS, 36/87 (41.4%) obese PWS and 39/85 (45.9%) obese controls. Non-obese PWS showed lower frequency for each MetS component as compared with obese PWS and obese controls. PWS patients with deletion of the chromosome 15q11-13 showed a lower risk for low HDL-C (p < 0.01) and a trend towards a lower MetS risk (p < 0.06) compared to subjects without deletion. CONCLUSION: Our findings suggest the main role that obesity status plays on the individual metabolic risk clustering in PWS adults. Early identification of MetS could be helpful to improve morbidity and prevent mortality in such patients.


Asunto(s)
Síndrome Metabólico/complicaciones , Síndrome de Prader-Willi/complicaciones , Adolescente , Adulto , Índice de Masa Corporal , Deleción Cromosómica , Cromosomas Humanos Par 15 , Estudios de Cohortes , Estudios Transversales , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/epidemiología , Humanos , Hipertensión/complicaciones , Hipertensión/epidemiología , Italia/epidemiología , Masculino , Análisis por Apareamiento , Síndrome Metabólico/epidemiología , Obesidad/complicaciones , Síndrome de Prader-Willi/genética , Prevalencia , Riesgo , Translocación Genética , Disomía Uniparental , Adulto Joven
6.
Colorectal Dis ; 14(2): 205-11, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21689317

RESUMEN

AIM: Doppler-guided transanal haemorrhoid dearterialization (THD) and stapler haemorrhoidopexy (SH) have been demonstrated to be less painful than the Milligan-Morgan procedure. The aim of this study was to compare the effectiveness of THD vs SH in the treatment of third-degree haemorrhoids in an equivalent trial. METHOD: One hundred and sixty-nine patients with third-degree haemorrhoids were randomized online to receive THD (n = 85) or SH (n = 84) in 10 Colorectal Units in which the staff were well trained in both techniques. The mean follow-up period was 17 (range 15-20) months. RESULTS: Early minor postoperative complications occurred in 30.6% of patients in the THD group and in 32.1% of patients in the SH group. Milder spontaneous pain and pain on defecation were reported in the THD group in the first postoperative week, but this was not statistically significant. Late complications were significantly higher (P = 0.028) in the SH group. Residual haemorrhoids persisted in 12 patients in the THD group and in six patients in the SH group (P = 0.14). Six patients in the SH group and 10 in the THD group underwent further treatment of haemorrhoids (P = 0.34). No differences were found in postoperative incontinence. The obstructed defecation score (ODS) was significantly higher in the SH group (P < 0.02). Improvement in quality of life was similar in both groups. Postoperative in-hospital stay was 1.14 days in the THD group and 1.31 days in the SH group (P = 0.03). CONCLUSION: Both THD and SH techniques are effective for the treatment of third-degree haemorrhoids in the medium term. THD has a better cost-effective ratio and lower (not significant) pain compared with SH. Postoperative pain and recurrence did not differ significantly between the two groups.


Asunto(s)
Canal Anal/cirugía , Hemorroides/cirugía , Grapado Quirúrgico , Adulto , Anciano , Canal Anal/irrigación sanguínea , Canal Anal/diagnóstico por imagen , Defecación , Femenino , Estudios de Seguimiento , Hemorroides/clasificación , Hemorroides/diagnóstico por imagen , Humanos , Análisis de Intención de Tratar , Tiempo de Internación , Ligadura/efectos adversos , Ligadura/métodos , Masculino , Persona de Mediana Edad , Dolor Postoperatorio/etiología , Hemorragia Posoperatoria/etiología , Calidad de Vida , Recurrencia , Grapado Quirúrgico/efectos adversos , Resultado del Tratamiento , Ultrasonografía Doppler , Adulto Joven
8.
Int J Obes (Lond) ; 34(8): 1319-27, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20231840

RESUMEN

AIMS/HYPOTHESIS: Visceral and intermuscular adipose tissue (IMAT) depots account for most obesity-related metabolic and cardiovascular complications. Muscle satellite cells (SCs) are mesenchymal stem cells giving rise to myotubes and also to adipocytes, suggesting their possible contribution to IMAT origin and expansion. We investigated the myogenic differentiation of SCs and the adipogenic potential of both preadipocytes and SCs from genetically obese Zucker rats (fa/fa), focusing on the role of Wnt signaling in these differentiation processes. METHODS: SCs were isolated by single-fiber technique from flexor digitorum brevis muscle and preadipocytes were extracted from subcutaneous adipose tissue (AT). Morphological features and gene expression profile were evaluated during in vitro myogenesis and adipogenesis. Wingless-type MMTV integration site family member 10b (Wnt10b) expression was quantified by quantitative PCR in skeletal muscle and AT. RESULTS: We did not observe any difference in the proliferation rate and in the myogenic differentiation of SCs from obese and lean rats. However, a decreased insulin-induced glucose uptake was present in myotubes originating from fa/fa rats. Under adipogenic conditions, preadipocytes and SCs of obese animals displayed an enhanced adipogenesis. Wnt10b expression was reduced in obese rats in both muscle and AT. CONCLUSIONS/INTERPRETATION: Our data suggest that the increase in different fat depots including IMAT and the reduced muscle insulin sensitivity, the major phenotypical alteration of obese Zucker rats, could be ascribed to an intrinsic defect, either genetically determined or acquired, still present in both muscle and fat precursors. The involvement of Wnt10b as a regulator of both adipogenesis and muscle-to-fat conversion is suggested.


Asunto(s)
Adipogénesis/fisiología , Tejido Adiposo/metabolismo , Resistencia a la Insulina/fisiología , Obesidad/metabolismo , Células Satélite del Músculo Esquelético/citología , Adipogénesis/genética , Animales , Diferenciación Celular/fisiología , Resistencia a la Insulina/genética , Masculino , Obesidad/genética , Ratas , Ratas Zucker , Células Satélite del Músculo Esquelético/metabolismo
9.
Carbohydr Polym ; 218: 343-354, 2019 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-31221339

RESUMEN

Taxifolin possesses gastroprotective property but is characterized by low water solubility, is instabile in alkaline medium, and is degraded by the intestinal bacteria flora. The purpose of the work was therefore to produce a gastroadhesive formulation to prolong taxifolin residence time and release in the stomach. We first demonstrated that taxifolin is stable in simulated gastric fluid with or without pepsin and mucus, and is able to cross pig gastric mucus layer and stomach mucosa. Next, gastromucoadhesive microparticles composed of Syloid® AL-1 mesoporous silica, chitosan and HPMC were produced using spray-drying. Microparticles were characterized by a spherical shape and a mean volume-equivalent diameter around 12 µm. The optimized microparticles were able to release taxifolin and to adhere to pig stomach mucosa for 5 h.


Asunto(s)
Quitosano/química , Portadores de Fármacos/química , Fármacos Gastrointestinales/química , Quercetina/análogos & derivados , Adhesividad , Animales , Liberación de Fármacos , Excipientes/química , Mucosa Gástrica/metabolismo , Microtecnología , Mimusops/química , Tamaño de la Partícula , Permeabilidad , Quercetina/química , Semillas/química , Dióxido de Silicio/química , Porcinos
10.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(4): 169-173, 2018 Apr.
Artículo en Inglés, Español | MEDLINE | ID: mdl-29398231

RESUMEN

OBJECTIVES: To determine whether patients with glaucoma and epiretinal membrane (ERM) use a greater proportion of prostaglandin analogues (PA) than a control group of patients with glaucoma without ERM. METHOD: A retrospective study of cases and controls was conducted in order to determine whether patients with glaucoma and ERM used a greater proportion of PA than a control group of patients with glaucoma without ERM. The diagnosis of de ERM was made by clinical examination and optical coherence tomography. RESULTS: The mean age of the cases was 77 years (SD: 8.68; 95% CI: 74.3-79.4), compared to the controls with 63 years (SD: 16.6; 95% CI: 70.1-78.5). The cases included 50% (n=26) men and 50% women (n=26), whereas in the controls 25.4% (n=16) of the cases were men and 74.6% (n=47) women. PA treatment was used in 59.6% (n=31) and 60.3% (n=38) of the cases and controls, respectively. There was no statistically significant difference in PA use between the 2groups (P=.939). CONCLUSIONS: In this study, an association between the use of AP and the development of ERM could not be demonstrated.


Asunto(s)
Membrana Epirretinal/inducido químicamente , Prostaglandinas Sintéticas/efectos adversos , Administración Tópica , Anciano , Femenino , Glaucoma/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Prostaglandinas Sintéticas/administración & dosificación , Estudios Retrospectivos
11.
J Vasc Access ; 7(2): 90-3, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16868904

RESUMEN

Pacemaker lead extraction has been shown to be an effective and safe treatment in the case of infected per-manent pacemaker leads. However, it can lead to potentially serious complications, usually occurring during the ex-traction procedure. This report describes a case of a 74-year-old male with a persistent superior vena cava thrombo-sis related to an infected permanent pacemaker lead transvenous extraction. Clinical and surgical management are discussed.


Asunto(s)
Remoción de Dispositivos/efectos adversos , Marcapaso Artificial , Infecciones Relacionadas con Prótesis/cirugía , Síndrome de la Vena Cava Superior/etiología , Anciano , Ecocardiografía , Humanos , Masculino
12.
Transplant Proc ; 37(4): 1902-4, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15919499

RESUMEN

INTRODUCTION: Recent studies from Europe have demonstrated that patients with end-stage renal disease who receive a kidney transplant are at an increased risk for rejection and graft loss when compared with patients who have no known thrombophilia. The role of anticoagulation has not been investigated in these patients. MATERIALS AND METHODS: We prospectively tested patients who were evaluated for a kidney transplant for 8 thrombophilias, protein S and C deficiencies, factor V Leiden mutation, antithrombin III deficiency, anticardiolipin antibody, lupus anticoagulant, prothrombin gene mutation, and heparin-induced platelet antibody (HIPA). Patients with any identified thrombophilia received heparin or argatroban (for HIPA (+) patients) followed by coumadin for 1 year after transplantation. Triple therapy included cyclosporine, prednisone, and CellCept (Roche Pharmaceuticals, Nutley, NJ, USA). Sensitized, black, or repeat transplantation patients received induction with an interleukin (IL)-2 inhibitor. Data were collected in a retrospective manner. Rejection was biopsy-proven. RESULTS: Of the 112 transplant recipients who were tested for thrombophilia, 37 had 1 or more thrombophilia and 75 had no thrombophilia identified. Twenty-six patients received heparin and 11 received argatroban. There were no differences in recipient age, cold storage time, graft loss, HLA match, rejection episodes, 1-year graft survival, or serum creatinine level at 1 year. Significant differences were noted in posttransplantation bleeding, 35% versus 5%, and delayed graft function, 32% versus 15%, in patients with thrombophilia versus no thrombophilia, respectively. CONCLUSION: This is the first study to demonstrate that there is no increase in rejection or graft loss in kidney transplant recipients with thrombophilia when treated with anticoagulation and triple immunosuppression.


Asunto(s)
Anticoagulantes/uso terapéutico , Rechazo de Injerto/epidemiología , Supervivencia de Injerto/fisiología , Inmunosupresores/uso terapéutico , Trasplante de Riñón/fisiología , Trombofilia/tratamiento farmacológico , Trombosis/tratamiento farmacológico , Arginina/análogos & derivados , Creatinina/sangre , Quimioterapia Combinada , Factor V/genética , Femenino , Heparina/uso terapéutico , Prueba de Histocompatibilidad , Humanos , Trasplante de Riñón/inmunología , Masculino , Persona de Mediana Edad , Mutación , Ácidos Pipecólicos/uso terapéutico , Sulfonamidas , Trombofilia/complicaciones , Trombosis/complicaciones
13.
Minerva Chir ; 70(5): 319-25, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26013762

RESUMEN

AIM: The aim of the present study was to assess the safety and efficacy of this new topical agent as a first line treatment in patients with chronic anal fissures. METHODS: Nine centres were involved in the study. Patients with chronic anal fissures were recruited and received Levorag® for 40 days. Follow-up visits were conducted at 10, 20 and 40 days from the recruitment. Primary outcome was the healing rate, secondary outcome the reduction of pain at the end of the treatment measured with a VAS scale. RESULTS: Fifty patients completed the treatment. No adverse events were recorded. 60% of patients healed completely at the end of the treatment. In those that did not heal the reduction of mean VAS values was 60%. CONCLUSION: The use of Levorag® on patients affected by chronic anal fissures achieved in the short term results similar to those experienced by more classic local treatments without any side effect.


Asunto(s)
Fármacos Dermatológicos/administración & dosificación , Emolientes/administración & dosificación , Fisura Anal/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , beta-Glucanos/administración & dosificación , Enfermedad Crónica , Combinación de Medicamentos , Estudios de Seguimiento , Geles/administración & dosificación , Humanos , Italia , Dimensión del Dolor , Resultado del Tratamiento , Cicatrización de Heridas
14.
Endocrinology ; 140(4): 1581-5, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10098491

RESUMEN

Leptin is secreted by adipocytes and regulates food intake and energy balance through the activation of specific receptors (OB-R). Recent evidence suggests that it is also involved in the control of reproductive processes, by possibly acting on central and peripheral targets. In particular, it has been shown that leptin may indirectly stimulate GnRH release from hypothalamic fragments by acting on interneurons impinging on GnRH-secreting neurons. The possibility that leptin might additionally modulate the activity of GnRH-secreting neurons in a direct way has been addressed in the present study, by using the immortalized GnRH-secreting cell line GT1-7. The presence of OB-R messenger RNA (mRNA) (long form) was detected by RT-PCR analysis of total RNA from GT1-7 cells. An OB-R protein is also expressed in these cells, as shown by immunocytochemistry and by Western blot analysis. The latter has revealed the presence of a single immunoreactive OB-R with an approximate size of 130 kDa. To study the functionality of these receptors, the effect of leptin treatment on GnRH secretion and gene expression in GT1-7 cells were evaluated. Under static conditions, GnRH release was stimulated by exposure to low concentrations of leptin (10(-12) M after 30 min; 10(-10) M after 60 min). The 10(-12) M dose was selected for studying the effect of leptin on GnRH secretion under dynamic conditions. To this purpose, GT1-7 cells were placed in a perifusion system; treatment with leptin (10(-12) M) for 60 min stimulated GnRH release with no changes of pulse frequency. On the contrary, exposure to leptin (10(-12)-10(-10) M) for 1, 3, 6, and 24 h did not affect GnRH gene expression in GT1-7 cells. The present results indicate that GT1-7 cells possess OB-Rs and that leptin may directly affect their function. Taken together with the available reports, these findings suggest that leptin might participate in the regulation of reproductive processes by acting at multiple levels, both centrally and peripherally.


Asunto(s)
Proteínas Portadoras/genética , Expresión Génica , Hormona Liberadora de Gonadotropina/metabolismo , Neuronas/metabolismo , Receptores de Superficie Celular , Animales , Western Blotting , Línea Celular Transformada , Hormona Liberadora de Gonadotropina/genética , Inmunohistoquímica , Cinética , Leptina , Ratones , Peso Molecular , Proteínas/farmacología , ARN Mensajero/análisis , Receptores de Leptina , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
15.
J Clin Endocrinol Metab ; 89(6): 2724-7, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15181048

RESUMEN

Myostatin is a member of transforming growth factor-beta superfamily that plays an important inhibitory role during muscle development; in fact mutations of myostatin gene result in a hypermuscular phenotype. Moreover myostatin-deficient mice have a significant reduction in fat depots and a depression of adipogenesis. Little is known about myostatin function in muscle growth regulation in humans and in particular during caloric restriction. In the present work we quantified by real-time RT-PCR myostatin expression in muscle biopsies of a group of morbidly obese patients before and after weight loss obtained by biliopancreatic diversion (BPD). The patients reduced body weight by 38.9%, mostly due to fat-mass loss, showing also a significant reduction in the 24-hour EE as assessed by the respiratory chamber. Myostatin mRNA levels result clearly decreased after weight loss, suggesting a role in counteracting the progressive decline of muscle mass after BPD. Myostatin may provide therefore another mechanistic explanation for the control of energy partitioning between protein and fat, working against muscle wasting. Our data suggest that myostatin might represent an important regulator of skeletal muscle size also in conditions of food restriction in obese subjects.


Asunto(s)
Músculo Esquelético/fisiología , Obesidad/fisiopatología , Factor de Crecimiento Transformador beta/genética , Pérdida de Peso/fisiología , Composición Corporal , Dieta Reductora , Metabolismo Energético/fisiología , Expresión Génica/fisiología , Humanos , Miostatina , Nitrógeno/orina , Obesidad/dietoterapia , Factor de Crecimiento Transformador beta/metabolismo
16.
Metabolism ; 46(6): 684-90, 1997 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9186306

RESUMEN

Plasma lactate is elevated in many physiological and pathological conditions, such as physical exercise, obesity, and diabetes, in which a reduction of insulin sensitivity is also present. Furthermore, an increased production of lactate from muscle and adipose tissue together with increased gluconeogenic substrate flux to the liver plays a primary role in enhancing hepatic glucose production (HGP) in diabetes. It has been shown that lactate may interfere with the utilization and oxidation of other substrates such as free fatty acids (FFAs). The aim of this study was to investigate if lactate infusion affects peripheral glucose utilization in rats. Animals were acutely infused with lactate to achieve a final lactate concentration of 4 mmol/L. They were then submitted to a euglycemic-hyperinsulinemic clamp to study HGP and overall glucose metabolism (rate of disappearance [Rd]). At the end of the clamp, a bolus of 2-deoxy-[1-3H]-glucose was injected to study insulin-dependent glucose uptake in different tissues. The results show that lactate infusion did not affect HGP either in the basal state or at the end of clamp, whereas glucose utilization significantly decreased in lactate-infused rats (26.6 +/- 1.1 v 19.5 +/- 1.4 mg.kg-1.min-1, P < .01). A reduction in the tissue glucose utilization index was noted in heart (18.01 +/- 4.44 v 46.21 +/- 6.51 ng.mg-1.min-1, P < .01), diaphragm (5.56 +/- 0.74 v 9.01 +/- 0.93 ng.mg-1.min-1, P < .01), soleus (13.62 +/- 2.29 v 34.05 +/- 6.08 ng.mg-1.min-1, P < .01), and red quadricep (4.43 +/- 0.73 v 5.88 +/- 0.32 ng.mg-1.min-1, P < .05) muscle in lactate-infused animals, whereas no alterations were observed in other muscles or in adipose tissue. Therefore, we suggest that acute lactate infusion induces insulin resistance in the heart and some muscles, thus supporting a role for lactate in the regulation of peripheral glucose metabolism.


Asunto(s)
Glucosa/metabolismo , Resistencia a la Insulina , Lactatos/farmacología , Músculo Esquelético/metabolismo , Miocardio/metabolismo , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Anestesia General , Animales , Bicarbonatos/administración & dosificación , Bicarbonatos/farmacología , Glucemia/metabolismo , Desoxiglucosa/metabolismo , Técnica de Clampeo de la Glucosa , Corazón/efectos de los fármacos , Infusiones Intravenosas , Lactatos/administración & dosificación , Lactatos/sangre , Masculino , Músculo Esquelético/efectos de los fármacos , Ratas , Ratas Sprague-Dawley
17.
Metabolism ; 48(8): 960-4, 1999 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10459558

RESUMEN

Leptin, the satiety hormone expressed almost exclusively in adipose tissue, is a marker of body fat accumulation in humans. Recent studies have shown that plasminogen activator inhibitor-1 (PAI-1), a prothrombotic factor associated with atherosclerosis complications, is also produced in adipose tissue. The objective of the present study was to determine whether PAI-1 antigen plasma concentrations are associated with leptin plasma levels or the body fat mass (FM) independently of the variables known to influence PAI-1 production. Sixty-one nondiabetic women aged 18 to 45 years with a wide range of values for the body mass index ([BMI] 18.1 to 37.7 kg/m2) were evaluated for (1) body FM and fasting plasma levels of (2) PAI-1 antigen, (3) PAI-1 activity, (4) leptin, (5) insulin, (6) blood glucose, and (7) lipids (cholesterol, high-density lipoprotein [HDL]-cholesterol, and triglycerides [TG]). Body FM and fat-free mass (FFM) were estimated during fasting conditions by the bioimpedance analysis (BIA) method using a tetrapolar device. Body fat distribution was evaluated by the waist circumference and the waist to hip ratio (WHR). FM was directly associated with both PAI-1 antigen (r = .585, P < .001) and PAI-1 activity (r = .339, P < .001). Seemingly, leptin was positively related to both PAI-1 antigen (r = .630, P < .001) and PAI-1 activity (r = .497, P < .001). Moreover, both PAI-I antigen and PAI-1 activity were directly correlated with FFM (r = .285, P < .05, and r = .336, P < .01, respectively), BMI (r = .594, P < .001, and r = .458, P < .001, respectively), and WHR (r = .510, P < .001, and r = .391, P < .005, respectively). Insulin was directly related to PAI-1 antigen (r = .540, P < .001), PAI-1 activity (r = .259, P < .05), leptin (r = .447, P < .001), and FM (r = .435, P < .001). The association between PAI-1 antigen (dependent variable) and leptin or FM was tested by a stepwise regression model simultaneously including leptin, FM, BMI, WHR, age, FFM, and fasting insulin, blood glucose, TG, cholesterol, and HDL-cholesterol as independent variables. PAI-1 antigen maintained a significant positive independent relationship only with leptin (t = 2.923, P < .01), insulin (t = 3.489, P < .001), and fasting blood glucose (t = 2.092, P < .05), and a negative independent relationship with HDL-cholesterol (t = -2.634, P < .05). In conclusion, the strong relationship between PAI-1 antigen and leptin irrespective of other variables known to influence these factors seems to indicate that leptin per se may potentially increase PAI-1 plasma concentrations in obese subjects.


Asunto(s)
Peso Corporal , Insulina/sangre , Inhibidor 1 de Activador Plasminogénico/sangre , Premenopausia/sangre , Proteínas/metabolismo , Tejido Adiposo/metabolismo , Adolescente , Adulto , Índice de Masa Corporal , Femenino , Humanos , Leptina , Persona de Mediana Edad
18.
Peptides ; 22(3): 415-20, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11287096

RESUMEN

Neuropeptide Y (NPY) participates in the regulation of reproduction and food intake. The adipose-secreted hormone, leptin, has also been involved in these processes, and has been shown to exert its effects in part by controlling NPY synthesis and release at the hypothalamic level. In the present study, we utilized the SH-SY5Y human neuroblastoma cell line, to study the leptin-NPY interrelationships. SH-SY5Y cells were found to express leptin receptors (RT-PCR and Western blot analyses). A 24-h treatment with leptin at different concentrations did not affect NPY gene expression, but resulted in a stimulation of NPY release. This stimulated secretion was blocked by the combined treatment with leptin and the muscarinic agonist carbachol or the phorbol ester TPA. Leptin and carbachol also caused an increased intracellular content of NPY. In conclusion, the SH-SY5Y human neuroblastoma cell line appears to be a suitable in vitro model for studying the pharmacological effects of leptin on the biosynthesis and secretion of NPY.


Asunto(s)
Leptina/metabolismo , Neuropéptido Y/biosíntesis , Neuropéptido Y/metabolismo , Northern Blotting , Western Blotting , Carbacol/química , Carbacol/metabolismo , Regulación de la Expresión Génica , Humanos , Leptina/química , Radioinmunoensayo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Tumorales Cultivadas
19.
Crit Rev Biomed Eng ; 28(1-2): 231-6, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10999393

RESUMEN

We report experiments directed at the ability of humans to perceive the spatial orientation of occluded objects, to position an occluded limb relative to targets or directions in the environment, and to match the spatial orientation of occluded contralateral limbs. Results suggest that each of these abilities is tied to the inertial eigenvectors of each object or limb, which correspond to the object's or limb's principal axes of rotational inertia. It is suggested that the mechanisms supporting the perception of intact limbs, neuropathic or anesthetized limbs, prosthetic devices, and hand-held tools and implements via kinesthesis may be one and the same--the detection of movement-produced physical invariants such as the inertia tensor. While the research reported presently has focused on the perception of intact limbs and hand-held objects, future research should be directed at possible generalizations of this work to a variety of clinical populations, including those involving peripheral neuropathies and prosthetic devices.


Asunto(s)
Cinestesia/fisiología , Percepción Espacial/fisiología , Brazo/fisiología , Miembros Artificiales , Mano/fisiología , Humanos , Modelos Biológicos , Enfermedades del Sistema Nervioso Periférico/psicología
20.
J Exp Psychol Hum Percept Perform ; 21(5): 1070-87, 1995 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7595243

RESUMEN

The ability of humans to perceive the spatial orientation of an occluded arm was investigated. It was hypothesized that this ability is tied to the arm's inertial eigenvectors, invariant mechanical parameters corresponding to a limb's axes of rotational symmetry. By breaking the coincidence between the eigenvectors of the arm and its longitudinal axis, 3 experiments were directed at the possibility that the perceived orientation of an occluded arm would vary as a function of the eigenvectors. Overall, the angles in which the arm was positioned were affected by the direction in which the eigenvectors of the limb were oriented by small appended masses. Discussion focused on the importance of physical invariants for proprioception.


Asunto(s)
Gravitación , Cinestesia , Orientación , Propiocepción , Adulto , Atención , Femenino , Humanos , Masculino , Psicofísica , Privación Sensorial , Soporte de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA